Asymmetric Synthesis II 2012
DOI: 10.1002/9783527652235.ch49
|View full text |Cite
|
Sign up to set email alerts
|

Total Synthesis of All (–)‐Agelastatin Alkaloids

Abstract: The pyrrole-imidazole family of marine alkaloids, derived from linear clathrodin-like precursors, constitutes a diverse array of structurally complex natural products. The bioactive agelastatins are members of this family that possess a tetracyclic molecular framework incorporating C4-C8 and C7-N12 bond connectivities. We provide a hypothesis for the formation of the unique agelastatin architecture that maximally exploits the intrinsic chemistry of plausible biosynthetic precursors. We report the concise enant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…3,4-Dihydropyrrolopyrazinones are unique structural motifs found in numerous biologically active natural products and medicinally relevant compounds and thus have received much attention in the organic and medicinal communities. For example, highly complex natural alkaloids such as immunosuppressive palau’amine, antimetastatic agelastatin A–F, cyclooroidin, phakellin, and anti-HIV investigational compound MK-2048 and aldose reductase inhibitor ranirestat all possess a 3,4-dihydro­pyrrolo­pyrazinone heterocyclic core (Figure ).…”
mentioning
confidence: 99%
“…3,4-Dihydropyrrolopyrazinones are unique structural motifs found in numerous biologically active natural products and medicinally relevant compounds and thus have received much attention in the organic and medicinal communities. For example, highly complex natural alkaloids such as immunosuppressive palau’amine, antimetastatic agelastatin A–F, cyclooroidin, phakellin, and anti-HIV investigational compound MK-2048 and aldose reductase inhibitor ranirestat all possess a 3,4-dihydro­pyrrolo­pyrazinone heterocyclic core (Figure ).…”
mentioning
confidence: 99%